Discovery of dihydroxy-enone-type protein-bound ceramides as the dominant type in human stratum corneum

This study reveals that dihydroxy-enone-type protein-bound ceramides, rather than the previously studied epoxy-enone types, are the predominant class in human stratum corneum and are likely generated via epoxide hydrolase EPHX3-mediated conversion, highlighting a fundamental structural difference between human and mouse skin barrier lipids.

The Gist

The Big Picture: The Skin's "Super Glue"

Imagine your skin is a brick wall. The "bricks" are your skin cells (corneocytes), and the "mortar" holding them together is a special layer of fat (lipids). This mortar is crucial because it keeps water inside your body and keeps germs and dirt outside.

Inside this mortar, there is a special type of "super glue" called protein-bound ceramides. These are unique fat molecules that are chemically stuck to the surface of the skin cells, acting like a scaffold to hold the whole wall together. If this glue is defective, the wall crumbles, leading to severe skin diseases like ichthyosis (fish-scale skin).

For a long time, scientists thought they knew exactly what this "glue" looked like, based mostly on studies of mice. But this new study reveals that human skin uses a completely different, previously unknown type of glue.

---

The Discovery: The "Epoxy" vs. The "Dihydroxy"

Think of the fat molecules in the glue as having a specific shape, like a key.

1. The Mouse Model (The "Epoxy" Key):
   Scientists previously found that in mice, the glue is made of a molecule called an Epoxy-Enone (EE) type. Imagine this molecule has a little "ring" or "loop" (an epoxy group) in its structure. This loop is very reactive; it acts like a hook that snaps onto the skin cell proteins, locking the fat in place. This works perfectly for mice.

2. The Human Surprise (The "Dihydroxy" Key):
   The researchers went to look for this same "Epoxy" glue in human skin. They found a tiny bit of it, but it wasn't the main player. Instead, they discovered a brand new type of glue that had never been seen before. They call it the Dihydroxy-Enone (DE) type.

   The Analogy: Imagine the "Epoxy" ring is a closed circle. In humans, it seems like a chemical "scissors" (an enzyme) snips that ring open and adds two extra water-based handles (hydroxyl groups) to it.

   • Mouse Glue: Has a closed loop (Epoxy).
   • Human Glue: Has an open loop with two extra handles (Dihydroxy).

Why Does This Matter?

The study found that in humans, this new "Dihydroxy" glue is the dominant type (about 6 times more common than the "Epoxy" type). In mice, it's the other way around; the "Epoxy" type is the boss, and the "Dihydroxy" type is rare.

Why the difference?
The authors suggest it's about how much the skin needs to rely on this "mortar."

• Mice: As mice grow up, they get thick fur and produce a lot of oil (sebum). Their hair and oil do a lot of the work protecting them from water loss. Their skin barrier (the mortar) can be thinner and simpler.
• Humans: We don't have thick fur. Our skin is our only shield against the world. To make a stronger, more robust wall, human skin uses the "Dihydroxy" glue. These extra handles allow the molecules to form stronger connections (like more hydrogen bonds), creating a tougher, more waterproof barrier suited for a hairless species.

The "Chemical Scissors" (Enzymes)

How does the body turn the "Epoxy" glue into the "Dihydroxy" glue? The researchers suspect a specific enzyme acts like a pair of scissors.

• They found that an enzyme called EPHX3 is responsible for cutting open that ring in the human skin.
• They noticed that as mice get older, the amount of this "scissors" enzyme increases, and the amount of the "Dihydroxy" glue also increases. This confirms that EPHX3 is the worker that transforms the glue.

The "Irreversible" Mystery

The study also noted that about 40% of the glue in both humans and mice is "irreversible"—meaning you can't wash it off or break it easily with chemicals. Scientists have a theory about this (the "P-O" model), where the fat is glued to the protein via a different chemical bond (like an ester link). However, they couldn't find direct proof of this specific structure yet. It's like finding a locked safe in the wall but not having the key to open it and see what's inside.

The Takeaway

This paper is a major update to our understanding of human skin.

1. We are not mice: What works for a mouse's skin barrier doesn't necessarily apply to humans.
2. New Discovery: Humans rely on a unique, "Dihydroxy" type of protein-bound ceramide that is stronger and more complex than the mouse version.
3. Medical Impact: Since defects in these ceramides cause severe skin diseases, knowing the exact structure of the human version helps scientists design better treatments for people with damaged skin barriers.

In short: Human skin has evolved a super-strong, specialized "glue" that is chemically distinct from our furry cousins, ensuring we stay hydrated and protected in a world without fur.

Technical Summary

1. Problem Statement

Protein-bound ceramides are essential components of the corneocyte lipid envelope (CLE), forming a scaffold for the skin's permeability barrier. Defects in their synthesis lead to severe skin disorders like ichthyosis. While two structural models for protein-bound ceramides have been proposed—the P-O model (protein-bound $\omega$-hydroxy fatty acid) and the P-EO model (protein-bound modified linoleic acid–esterified $\omega$-hydroxy fatty acid)—the precise molecular structures in humans remained incompletely defined.

Previous research established that epoxy-enone (EE)-type P-EO ceramides are the predominant form in mouse epidermis. However, it was unclear if this structure is conserved in human skin. The unique covalent linkage between the lipid and protein components, combined with their distinct physicochemical properties, has historically posed significant technical challenges for structural elucidation.

2. Methodology

The study employed a combination of advanced mass spectrometry, chemical derivatization, and comparative biology (human vs. mouse) to characterize protein-bound ceramides.

• Sample Collection:
  • Human: Stratum corneum (SC) collected via tape stripping from healthy volunteers.
  • Mouse: Epidermis and SC collected from postnatal day 0 (P0), 1-month, and 3-month-old C57BL/6J mice.
• Lipid Extraction & Release:
  • Free lipids were removed via organic solvent washing.
  • Oxidative Sulfoxide Elimination: Protein-bound ceramides were treated to release their acylceramide moieties. This reaction specifically releases ceramides where the protein is linked via a Michael addition to an enone group (reversible type), converting them back to free acylceramides for analysis.
  • Alkaline Hydrolysis: Used to convert all protein-bound ceramides (reversible and irreversible) into $\omega$-hydroxyceramides for total quantification.
• Mass Spectrometry Analysis (LC-MS/MS):
  • Precursor-ion scanning (Positive mode): Detected sphingosine-containing ceramides ($m/z$ 264).
  • Product-ion scanning (Negative mode): Analyzed fragmentation patterns to distinguish structural differences between EE and dihydroxy-enone (DE) forms.
  • Multiple Reaction Monitoring (MRM): Used for precise quantification of specific EE and DE species.
• Gene Expression Analysis:
  • Quantitative real-time RT-PCR was used to measure expression levels of epoxide hydrolase genes (Ephx2 and Ephx3) in mouse skin at different developmental stages.

3. Key Contributions

• Discovery of a New Dominant Class: The study identified a previously unrecognized class of protein-bound ceramides in human skin, termed dihydroxy-enone (DE)-type P-EO ceramides, which are the predominant form in humans.
• Species-Specific Divergence: The paper establishes a fundamental difference in skin barrier architecture between humans and mice: humans rely on DE-type ceramides, while mice rely on EE-type ceramides.
• Stereochemical Resolution: The study resolved the stereochemistry of DE acylceramides, identifying them as diastereomers with (9R,10S) and (9R,10R) configurations.
• Enzymatic Mechanism: The research links the formation of the (9R,10S) DE stereoisomer to the enzyme EPHX3 (epoxide hydrolase 3).

4. Key Results

• Structural Identification:
  • In human SC, EE-type acylceramides were barely detectable. Instead, prominent peaks corresponding to DE acylceramides were observed.
  • MS/MS analysis revealed that DE acylceramides are hydrated forms of EE acylceramides, where the epoxide ring has been hydrolyzed to a diol structure.
  • DE acylceramides appeared as two distinct chromatographic peaks (peaks 1/2 and 3/4), corresponding to the (9R,10S) and (9R,10R) stereoisomers.
• Quantitative Abundance:
  • Humans: DE-type ceramides were approximately 6-fold more abundant than EE-type ceramides.
  • Mice: EE-type ceramides were the dominant form (approx. 93% of total), with DE-types comprising only ~7%.
  • This ratio difference persisted regardless of sampling depth (tape-stripped SC vs. full epidermis) or age (neonatal vs. adult), confirming it is a species-specific trait.
• Reversibility:
  • Approximately 60% of human protein-bound ceramides were "reversible" (released via oxidative sulfoxide elimination), consistent with the P-EO (DE) structure. The remaining 40% were "irreversible," the structure of which remains to be fully elucidated (potentially P-O type or other covalent modifications).
• Role of EPHX3:
  • Expression of Ephx3 increased significantly with age in mice (2.6-fold at 1 month, 4.2-fold at 3 months).
  • The abundance of the (9R,10S) DE stereoisomer (Peak A) correlated strongly with Ephx3 expression levels.
  • This suggests EPHX3 catalyzes the hydrolysis of the epoxide ring in EE acylceramides to generate the (9R,10S) DE acylceramides.
• Biological Implications:
  • The higher hydroxyl content in human DE ceramides (two additional hydroxyl groups compared to mouse EE ceramides) suggests stronger hydrogen bonding capabilities. This may contribute to the robustness of the human skin barrier, which relies more heavily on the SC compared to mice (whose barrier relies increasingly on hair and sebum post-natally).

5. Significance

• Molecular Basis for Skin Barrier: The findings provide a critical molecular basis for understanding how the skin barrier is constructed in humans versus mice. This is vital for interpreting mouse models of human skin diseases, as the lipid architecture differs fundamentally.
• Pathology of Ichthyosis: Since mutations in genes responsible for protein-bound ceramide synthesis cause ichthyosis, understanding the specific DE-structure in humans is essential for diagnosing and treating these disorders.
• Enzymatic Pathway Elucidation: The identification of EPHX3 as a key player in generating the specific (9R,10S) stereoisomer opens new avenues for investigating the biosynthetic pathway of skin lipids.
• Future Directions: The study highlights the need to characterize the "irreversible" fraction of protein-bound ceramides and further investigate the roles of EPHX2 and EPHX3 in human skin to fully map the biosynthesis of the corneocyte lipid envelope.